REINHARDT MAX
SEC CIK 1780058 · EDGAR
BoughtSold
Most active insiders at OFIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Engine Capital Management, LP | 10% | $2.23M | — |
| 2 | Ajdler Arnaud | 10% | $1.74M | — |
| 3 | Calafiore Massimo | Pres, CEO, Dir | — | $456.5K |
| 4 | Andrews Julie | CFO | — | $131.1K |
| 5 | Cedron Jorge Andres | CLO | — | $83.3K |
| 6 | Vitale Lucas | CP, BOO | — | $80.3K |
| 7 | McPherron Aviva | Pres, Gbl Ops, Qual | — | $67.0K |
| 8 | CAPPS VICKIE L | Dir | $62.3K | — |
| 9 | HENNEMAN JOHN B III | Dir | $61.3K | — |
| 10 | Fisher Patrick | Pres, Gbl Limb Recon | — | $34.0K |
| 11 | REINHARDT MAX | Pres, Gbl Spine | — | $27.2K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-06 | 2026-03-04+ | OFIX | Orthofix Medical Inc. | REINHARDT MAX | Pres, Gbl Spine | S - Sale | $12.74 | -2,133 | 25.3K | -8% | -$27.2K |
| 2025-06-13 | 2025-06-11 | OFIX | Orthofix Medical Inc. | REINHARDT MAX | Pres, Gbl Spine | S - Sale | $11.64 | -1,643 | 27.5K | -6% | -$19.1K | |
| D | 2025-03-05 | 2025-03-03 | OFIX | Orthofix Medical Inc. | REINHARDT MAX | Pres, Gbl Spine | A - Grant | $0.00 | +14.7K | 29.1K | +102% | $0 |
| D | 2024-06-12 | 2024-06-10 | OFIX | Orthofix Medical Inc. | REINHARDT MAX | Pres, Gbl Spine | A - Grant | $13.02 | +14.4K | 14.4K | New | +$187.5K |
| M | 2023-06-07 | 2023-06-06+ | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | S - Sale | $38.42 | -2,153 | 30.3K | -7% | -$82.7K |
| 2022-10-11 | 2022-10-07 | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | S - Sale | $58.00 | -1,380 | 31.4K | -4% | -$80.0K | |
| DM | 2022-06-08 | 2022-06-06+ | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | S - Sale | $61.66 | -5,250 | 24.4K | -18% | -$323.7K |
| D | 2022-06-08 | 2022-06-08 | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | A - Grant | $0.00 | +7,950 | 32.2K | +33% | $0 |
| D | 2022-04-25 | 2022-04-21 | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | S - Sale+OE | $73.25 | -9,824 | 29.6K | -25% | -$719.6K |
| D | 2022-04-25 | 2022-04-21 | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | M - OptEx | $42.54 | +12.5K | 39.5K | +46% | +$531.8K |
| DM | 2022-04-20 | 2022-04-18+ | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | M - OptEx | $42.54 | +37.5K | 30.0K | New | +$1.60M |
| DM | 2022-04-20 | 2022-04-18+ | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | S - Sale+OE | $73.27 | -28.0K | 27.0K | -51% | -$2.05M |
| 2021-07-06 | 2021-07-02 | PCRX | Pacira BioSciences, Inc. | REINHARDT MAX | Pres, Rest of World | S - Sale | $59.76 | -421 | 17.5K | -2% | -$25.2K |
Purchase Sale Sale after option exercise All abbreviations